An Experience with Cuban Biotech's Nasalferon to Prevent SARS-COV-2 Infections in International Travelers and their Contacts.

IF 1.8 4区医学 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Medicc Review Pub Date : 2021-04-01 Epub Date: 2021-04-02 DOI:10.37757/MR2021.V23.N2.1

Roberto Cañete, Lizbet M León, Layvis Rodríguez

引用次数: 1

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

古巴生物技术公司纳沙非龙预防国际旅行者及其接触者感染SARS-COV-2的经验

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Medicc Review PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH-

CiteScore

3.30

自引率

9.50%

发文量

审稿时长

>12 weeks

期刊介绍： Uphold the highest standards of ethics and excellence, publishing open-access articles in English relevant to global health equity that offer the best of medical, population health and social sciences research and perspectives by Cuban and other developing-country professionals.

期刊最新文献

Executive Summary: Insights from Cuba's COVID-19 Vaccine Enterprise: Report from a High Level Fact-Finding Delegation to Cuba. COVID-19, Viruses and Dementia. Full Technical Report: Insights from Cuba's COVID-19 Vaccine Enterprise: Report from a High Level Fact-Finding Delegation to Cuba. Health Care is a Right, Not a Commodity: The Legacy of Dr Paul Farmer MD PhD. Validation of a New Diagnostic Index to Determine Metabolic Obesity Phenotypes in Normal-Weight Women in Early Pregnancy.